Development of test systems for the discovery of selective human aldosterone synthase (CYP11B2) and 11β-hydroxylase (CYP11B1) inhibitors.: Discovery of a new lead compound for the therapy of congestive heart failure, myocardial fibrosis and hypertension

Autor: Bureik, Matthias, Hübel, Katja, Dragan, Calin-Aurel, Scher, Jochen, Becker, Hans, Lenz, Natalie, Bernhardt, Rita
Zdroj: In Molecular and Cellular Endocrinology 2004 217(1):249-254
Databáze: ScienceDirect